Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(8%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
25%
Ph phase_2
2
17%
Ph phase_3
1
8%
Ph phase_4
2
17%
Ph phase_1
3
25%

Phase Distribution

3

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
3(27.3%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(7)
Terminated(1)
Other(2)

Detailed Status

Completed7
unknown2
Recruiting1
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (27.3%)
Phase 22 (18.2%)
Phase 31 (9.1%)
Phase 42 (18.2%)
N/A3 (27.3%)

Trials by Status

recruiting18%
not_yet_recruiting18%
completed758%
withdrawn18%
unknown217%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12